MEDICATION commonly used to treat blood cholesterol could be used to treat prostate cancer that has stopped responding to hormone treatment, scientists have found.
A clinical trial with 12 participants found that statins slowed tumour growth when given alongside treatment which reduces hormone levels (androgen deprivation therapy).
The research, conducted by the Beatson West of Scotland Cancer Centre, has been welcomed by ex-soldier, John Culling, 64, who was diagnosed with an aggressive form of prostate cancer in 2019.
The first indication for him was finding he had to go to the toilet during the night.
READ MORE: Rise in number of residential rehabilitation places approved in Scotland
“I wasn’t overly concerned. I was only having to get up once in the night, but I had never had to before, so it was the change that prompted me to get it checked out,” he said.
“The diagnosis came as a shock. I was 60 but I had been in the army all my life so was fit.”
Culling received chemotherapy, radiotherapy and hormone treatment which was successful and is now being monitored, but given the aggressiveness of the cancer, it could return.
The grandfather, who lives in Broughty Ferry, near Dundee, said: “The aggressiveness of the prostate cancer I have, means there is a high chance it could come back so it’s a case of waiting and watching.”
Welcoming the breakthrough, funded by Cancer Research, Culling says he hopes those who are diagnosed with the disease in the future have “even better outcomes”.
He said: “Knowing that scientists are working in labs and hospitals conducting research and clinical trials, especially with drugs that are already in use for other conditions, gives me hope both for myself and for future generations.
“Hopefully, research like this means even better outcomes for anyone who might have to go through a diagnosis like mine.”
Larger clinical trials will need to take place to confirm whether statins could be given alongside androgen deprivation therapy to treat prostate cancer more widely.
About 3800 men in Scotland are diagnosed with prostate cancer annually.
READ MORE: Humza Yousaf welcomes 'immediate improvement' in A&E waiting times
Professor Hing Leung, of the Cancer Research UK Beatson Institute in Glasgow, who led the research, said: “Our study is the first of its kind to show statins having a detectable effect on prostate cancer growth in patients.
“We think statins could stop prostate cancer from making androgens from cholesterol, cutting off a route for cancer to resist androgen deprivation therapy.
“Castration-resistant prostate cancer, when cancer becomes resistant to hormone therapy, is currently very difficult to treat. If further trials are successful, we could use these already-approved medicines very quickly to offer patients better options for treatment.
“We need to test statins in a larger group of patients over a longer period to fully understand the benefits and risks to patients. But this data gives us hope that we could have some more readily-available treatments for prostate cancer in the future.”
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here